Recent trends in the initial therapy for newly diagnosed prostate cancer in Japan

Mizuki Onozawa, Shiro Hinotsu, Taiji Tsukamoto, Mototsugu Oya, Osamu Ogawa, Tadaichi Kitamura, Kazuhiro Suzuki, Seiji Naito, Mikio Namiki, Kazuo Nishimura, Yoshihiko Hirao, Hideyuki Akaza

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

OBJECTIVE: The objective of the present study was to investigate the trends over time in the initial treatment of prostate cancer in Japan.

METHODS: A total of 8291 patients with newly diagnosed prostate cancer whose treatment started in 2010 were registered in a multi-institutional observational study undertaken nationwide across Japan by the Japan Prostate Cancer Study Group. Each patient's background characteristics and initial treatment were recorded.

RESULTS: The median age at diagnosis was 71 years. The proportion of T1c disease was 40.5% and that of M1 disease was 10.4%. The prostate-specific antigen level was <10 ng/ml in 52.0% of the patients. High-, intermediate- and low-risk patients as determined by D'Amico's classification system made up 19.3, 29.8 and 25.9% of the cases, respectively. The initial treatment was androgen depletion therapy in 40.2%, radical prostatectomy in 32.0% (17.3% of these involved laparoscopic prostatectomy), radiation in 21.0% (46.4% of these involved brachytherapy). In cases of organ-confined disease, radical prostatectomy was selected in 39.5%, androgen depletion therapy in 28.0% and radiation in 23.9%. In D'Amico's low-risk group, the proportion treated with radiation was nearly equal to that treated with radical prostatectomy (30.2 and 32.7%, respectively); 73.2% of the radiation treatments involved brachytherapy.

CONCLUSION: Compared with previous Japanese studies, radiation use was increased by ∼10%. This increased proportion of radiation use was a typical trend in initial therapy for newly diagnosed prostate cancer cases in Japan. Although androgen depletion therapy use was decreased, it was selected in a high proportion of the patients irrespective of the disease stage.

Original languageEnglish
Pages (from-to)969-981
Number of pages13
JournalJapanese Journal of Clinical Oncology
Volume44
Issue number10
DOIs
Publication statusPublished - 2014 Oct 1
Externally publishedYes

Fingerprint

Prostatic Neoplasms
Japan
Radiation
Prostatectomy
Androgens
Therapeutics
Brachytherapy
Prostate-Specific Antigen
Observational Studies

Keywords

  • androgen depletion therapy
  • J-CaP
  • prostate cancer
  • prostatectomy
  • radiation

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Onozawa, M., Hinotsu, S., Tsukamoto, T., Oya, M., Ogawa, O., Kitamura, T., ... Akaza, H. (2014). Recent trends in the initial therapy for newly diagnosed prostate cancer in Japan. Japanese Journal of Clinical Oncology, 44(10), 969-981. https://doi.org/10.1093/jjco/hyu104

Recent trends in the initial therapy for newly diagnosed prostate cancer in Japan. / Onozawa, Mizuki; Hinotsu, Shiro; Tsukamoto, Taiji; Oya, Mototsugu; Ogawa, Osamu; Kitamura, Tadaichi; Suzuki, Kazuhiro; Naito, Seiji; Namiki, Mikio; Nishimura, Kazuo; Hirao, Yoshihiko; Akaza, Hideyuki.

In: Japanese Journal of Clinical Oncology, Vol. 44, No. 10, 01.10.2014, p. 969-981.

Research output: Contribution to journalArticle

Onozawa, M, Hinotsu, S, Tsukamoto, T, Oya, M, Ogawa, O, Kitamura, T, Suzuki, K, Naito, S, Namiki, M, Nishimura, K, Hirao, Y & Akaza, H 2014, 'Recent trends in the initial therapy for newly diagnosed prostate cancer in Japan', Japanese Journal of Clinical Oncology, vol. 44, no. 10, pp. 969-981. https://doi.org/10.1093/jjco/hyu104
Onozawa, Mizuki ; Hinotsu, Shiro ; Tsukamoto, Taiji ; Oya, Mototsugu ; Ogawa, Osamu ; Kitamura, Tadaichi ; Suzuki, Kazuhiro ; Naito, Seiji ; Namiki, Mikio ; Nishimura, Kazuo ; Hirao, Yoshihiko ; Akaza, Hideyuki. / Recent trends in the initial therapy for newly diagnosed prostate cancer in Japan. In: Japanese Journal of Clinical Oncology. 2014 ; Vol. 44, No. 10. pp. 969-981.
@article{ad0ffbc0dabd4f149462a9918cc308d0,
title = "Recent trends in the initial therapy for newly diagnosed prostate cancer in Japan",
abstract = "OBJECTIVE: The objective of the present study was to investigate the trends over time in the initial treatment of prostate cancer in Japan.METHODS: A total of 8291 patients with newly diagnosed prostate cancer whose treatment started in 2010 were registered in a multi-institutional observational study undertaken nationwide across Japan by the Japan Prostate Cancer Study Group. Each patient's background characteristics and initial treatment were recorded.RESULTS: The median age at diagnosis was 71 years. The proportion of T1c disease was 40.5{\%} and that of M1 disease was 10.4{\%}. The prostate-specific antigen level was <10 ng/ml in 52.0{\%} of the patients. High-, intermediate- and low-risk patients as determined by D'Amico's classification system made up 19.3, 29.8 and 25.9{\%} of the cases, respectively. The initial treatment was androgen depletion therapy in 40.2{\%}, radical prostatectomy in 32.0{\%} (17.3{\%} of these involved laparoscopic prostatectomy), radiation in 21.0{\%} (46.4{\%} of these involved brachytherapy). In cases of organ-confined disease, radical prostatectomy was selected in 39.5{\%}, androgen depletion therapy in 28.0{\%} and radiation in 23.9{\%}. In D'Amico's low-risk group, the proportion treated with radiation was nearly equal to that treated with radical prostatectomy (30.2 and 32.7{\%}, respectively); 73.2{\%} of the radiation treatments involved brachytherapy.CONCLUSION: Compared with previous Japanese studies, radiation use was increased by ∼10{\%}. This increased proportion of radiation use was a typical trend in initial therapy for newly diagnosed prostate cancer cases in Japan. Although androgen depletion therapy use was decreased, it was selected in a high proportion of the patients irrespective of the disease stage.",
keywords = "androgen depletion therapy, J-CaP, prostate cancer, prostatectomy, radiation",
author = "Mizuki Onozawa and Shiro Hinotsu and Taiji Tsukamoto and Mototsugu Oya and Osamu Ogawa and Tadaichi Kitamura and Kazuhiro Suzuki and Seiji Naito and Mikio Namiki and Kazuo Nishimura and Yoshihiko Hirao and Hideyuki Akaza",
year = "2014",
month = "10",
day = "1",
doi = "10.1093/jjco/hyu104",
language = "English",
volume = "44",
pages = "969--981",
journal = "Japanese Journal of Clinical Oncology",
issn = "0368-2811",
publisher = "Oxford University Press",
number = "10",

}

TY - JOUR

T1 - Recent trends in the initial therapy for newly diagnosed prostate cancer in Japan

AU - Onozawa, Mizuki

AU - Hinotsu, Shiro

AU - Tsukamoto, Taiji

AU - Oya, Mototsugu

AU - Ogawa, Osamu

AU - Kitamura, Tadaichi

AU - Suzuki, Kazuhiro

AU - Naito, Seiji

AU - Namiki, Mikio

AU - Nishimura, Kazuo

AU - Hirao, Yoshihiko

AU - Akaza, Hideyuki

PY - 2014/10/1

Y1 - 2014/10/1

N2 - OBJECTIVE: The objective of the present study was to investigate the trends over time in the initial treatment of prostate cancer in Japan.METHODS: A total of 8291 patients with newly diagnosed prostate cancer whose treatment started in 2010 were registered in a multi-institutional observational study undertaken nationwide across Japan by the Japan Prostate Cancer Study Group. Each patient's background characteristics and initial treatment were recorded.RESULTS: The median age at diagnosis was 71 years. The proportion of T1c disease was 40.5% and that of M1 disease was 10.4%. The prostate-specific antigen level was <10 ng/ml in 52.0% of the patients. High-, intermediate- and low-risk patients as determined by D'Amico's classification system made up 19.3, 29.8 and 25.9% of the cases, respectively. The initial treatment was androgen depletion therapy in 40.2%, radical prostatectomy in 32.0% (17.3% of these involved laparoscopic prostatectomy), radiation in 21.0% (46.4% of these involved brachytherapy). In cases of organ-confined disease, radical prostatectomy was selected in 39.5%, androgen depletion therapy in 28.0% and radiation in 23.9%. In D'Amico's low-risk group, the proportion treated with radiation was nearly equal to that treated with radical prostatectomy (30.2 and 32.7%, respectively); 73.2% of the radiation treatments involved brachytherapy.CONCLUSION: Compared with previous Japanese studies, radiation use was increased by ∼10%. This increased proportion of radiation use was a typical trend in initial therapy for newly diagnosed prostate cancer cases in Japan. Although androgen depletion therapy use was decreased, it was selected in a high proportion of the patients irrespective of the disease stage.

AB - OBJECTIVE: The objective of the present study was to investigate the trends over time in the initial treatment of prostate cancer in Japan.METHODS: A total of 8291 patients with newly diagnosed prostate cancer whose treatment started in 2010 were registered in a multi-institutional observational study undertaken nationwide across Japan by the Japan Prostate Cancer Study Group. Each patient's background characteristics and initial treatment were recorded.RESULTS: The median age at diagnosis was 71 years. The proportion of T1c disease was 40.5% and that of M1 disease was 10.4%. The prostate-specific antigen level was <10 ng/ml in 52.0% of the patients. High-, intermediate- and low-risk patients as determined by D'Amico's classification system made up 19.3, 29.8 and 25.9% of the cases, respectively. The initial treatment was androgen depletion therapy in 40.2%, radical prostatectomy in 32.0% (17.3% of these involved laparoscopic prostatectomy), radiation in 21.0% (46.4% of these involved brachytherapy). In cases of organ-confined disease, radical prostatectomy was selected in 39.5%, androgen depletion therapy in 28.0% and radiation in 23.9%. In D'Amico's low-risk group, the proportion treated with radiation was nearly equal to that treated with radical prostatectomy (30.2 and 32.7%, respectively); 73.2% of the radiation treatments involved brachytherapy.CONCLUSION: Compared with previous Japanese studies, radiation use was increased by ∼10%. This increased proportion of radiation use was a typical trend in initial therapy for newly diagnosed prostate cancer cases in Japan. Although androgen depletion therapy use was decreased, it was selected in a high proportion of the patients irrespective of the disease stage.

KW - androgen depletion therapy

KW - J-CaP

KW - prostate cancer

KW - prostatectomy

KW - radiation

UR - http://www.scopus.com/inward/record.url?scp=84920403545&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920403545&partnerID=8YFLogxK

U2 - 10.1093/jjco/hyu104

DO - 10.1093/jjco/hyu104

M3 - Article

C2 - 25098707

AN - SCOPUS:84920403545

VL - 44

SP - 969

EP - 981

JO - Japanese Journal of Clinical Oncology

JF - Japanese Journal of Clinical Oncology

SN - 0368-2811

IS - 10

ER -